<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Definitions of hematologic, cytogenetic, and molecular response in chronic myeloid leukemia&lt;sup&gt;[1,2]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Definitions of hematologic, cytogenetic, and molecular response in chronic myeloid leukemia<sup>[1,2]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Definitions of hematologic, cytogenetic, and molecular response in chronic myeloid leukemia<sup>[1,2]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup width="80%"></colgroup> <tbody> <tr> <td class="subtitle1">Response by type</td> <td class="subtitle1">Definitions</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Hematologic</td> </tr> <tr> <td class="indent1" rowspan="5">Complete</td> <td>WBC &lt;10 × 10<sup>9</sup>/L</td> </tr> <tr> <td>Basophils &lt;5%</td> </tr> <tr> <td>No myelocytes, promyelocytes, myeloblasts in the differential</td> </tr> <tr> <td>Platelet count &lt;450 × 10<sup>9</sup>/L</td> </tr> <tr> <td>Spleen nonpalpable</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Cytogenetic*</td> </tr> <tr> <td class="indent1" rowspan="2">Major</td> <td>Complete: No Ph+ metaphases or &lt;1% BCR::ABL1-positive nuclei of ≥200 nuclei on FISH</td> </tr> <tr> <td>Partial: 1 to 35% Ph+ metaphases</td> </tr> <tr> <td class="indent1">Minor</td> <td>36 to 65% Ph+ metaphases</td> </tr> <tr> <td class="indent1">Minimal</td> <td>66 to 95% Ph+ metaphases</td> </tr> <tr> <td class="indent1">None</td> <td>&gt;95% Ph+ metaphases</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Molecular<sup>¶</sup></td> </tr> <tr> <td class="indent1">MR<sup>4.5</sup></td> <td> <p>Detectable disease with ratio of <em>BCR::ABL1</em> to <em>ABL1</em> (or other housekeeping genes) ≤0.0032% (≥4.5 log reduction) on the international scale (IS)</p> <p><strong>or</strong></p> Undetectable disease in cDNA with ≥32,000 <em>ABL1</em> transcripts</td> </tr> <tr> <td class="indent1">MR<sup>4</sup></td> <td> <p>Detectable disease with ratio of <em>BCR::ABL1</em> to <em>ABL1</em> ≤0.01% (≥4 log reduction) on the IS</p> <p><strong>or</strong></p> Undetectable disease in cDNA with ≥10,000 <em>ABL1</em> transcripts</td> </tr> <tr> <td class="indent1">MR<sup>3</sup></td> <td>Detectable disease with ratio of <em>BCR::ABL1</em> to <em>ABL1</em> (or other housekeeping genes) ≤0.1% (≥3 log reduction) on the IS</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>WBC: white blood cell; Ph+: Philadelphia chromosome positive; FISH: fluorescence in situ hybridization; IS: international scale.</p>
<p>* Chromosome banding analysis of ≥20 bone marrow cell metaphases is necessary to determine the degree of cytogenetic response. If marrow cell metaphases cannot be obtained or evaluated by chromosome banding analysis, the definition of CCyR may be based on interphase fluorescence in situ hybridization of blood cells, provided that it is performed with <em>BCR::ABL1</em> extrasignal, dual color, dual fusion, or in situ hybridization probes, and that ≥200 nuclei are scored.</p>
¶ Molecular responses are, in general, reported on the evaluation of blood, not marrow samples. For a standardized assessment of the MolR, the conversion of each laboratory datum to the international scale (IS) is recommended, to correct for the variability of the assays in different laboratories. To allow for intra-laboratory variations, a fluctuation of less than one log requires confirmation.</div><div class="graphic_reference">Data from:
<ol>
<li>Baccarani M, Cortes J, Pane F, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009; 27:6041.</li>
<li>Baccarani M, Deininger MW, Rosti G, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 2013; 122:872.</li>
</ol></div><div id="graphicVersion">Graphic 52082 Version 13.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
